BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 14509153)

  • 1. Effect of garlic on lipid profile and psychopathologic parameters in people with mild to moderate hypercholesterolemia.
    Peleg A; Hershcovici T; Lipa R; Anbar R; Redler M; Beigel Y
    Isr Med Assoc J; 2003 Sep; 5(9):637-40. PubMed ID: 14509153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effect of garlic extract supplement on serum lipid levels in hypercholesterolemic subjects.
    Satitvipawee P; Rawdaree P; Indrabhakti S; Ratanasuwan T; Getn-gern P; Viwatwongkasem C
    J Med Assoc Thai; 2003 Aug; 86(8):750-7. PubMed ID: 12948274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of blood lipid parameters by a 12-wk supplementation of aged black garlic: a randomized controlled trial.
    Jung ES; Park SH; Choi EK; Ryu BH; Park BH; Kim DS; Kim YG; Chae SW
    Nutrition; 2014 Sep; 30(9):1034-9. PubMed ID: 24976429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women.
    Rios DR; Rodrigues ET; Cardoso AP; Montes MB; Franceschini SA; Toloi MR
    Nutrition; 2008; 24(11-12):1153-8. PubMed ID: 18842392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men.
    Anderson JW; Zettwoch N; Feldman T; Tietyen-Clark J; Oeltgen P; Bishop CW
    Arch Intern Med; 1988 Feb; 148(2):292-6. PubMed ID: 3277558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial.
    Maron DJ; Lu GP; Cai NS; Wu ZG; Li YH; Chen H; Zhu JQ; Jin XJ; Wouters BC; Zhao J
    Arch Intern Med; 2003 Jun; 163(12):1448-53. PubMed ID: 12824094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
    Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of pravastatin once daily in primary moderate hypercholesterolemia: the Israeli experience.
    Beigel Y; Brook G; Eisenberg S; Fainaru M; Harats D; Levy Y; Rubinstein A; Skurnik Y
    Isr J Med Sci; 1993 May; 29(5):272-7. PubMed ID: 8314685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of plant sterols is not influenced by dietary cholesterol intake in hypercholesterolemic individuals.
    Kassis AN; Vanstone CA; AbuMweis SS; Jones PJ
    Metabolism; 2008 Mar; 57(3):339-46. PubMed ID: 18249205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correction of hyperlipidemia with Allicor].
    Andrianova IV; Demidova OM; Medvedeva LA; Latyshev OA
    Klin Med (Mosk); 2004; 82(4):56-8. PubMed ID: 15164512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid effects of a dietary supplement softgel capsule containing plant sterols/stanols in primary hypercholesterolemia.
    Maki KC; Lawless AL; Reeves MS; Kelley KM; Dicklin MR; Jenks BH; Shneyvas E; Brooks JR
    Nutrition; 2013 Jan; 29(1):96-100. PubMed ID: 22796122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE; Ose L; Fraser N; Tribble DL; Quinto K; Reyes R; Johnson-Levonas AO; Sapre A; Donahue SR;
    Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carob pulp preparation rich in insoluble fibre lowers total and LDL cholesterol in hypercholesterolemic patients.
    Zunft HJ; Lüder W; Harde A; Haber B; Graubaum HJ; Koebnick C; Grünwald J
    Eur J Nutr; 2003 Oct; 42(5):235-42. PubMed ID: 14569404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.